Nasal CPAP: an objective evaluation of patient compliance
- PMID: 8111574
- DOI: 10.1164/ajrccm.149.1.8111574
Nasal CPAP: an objective evaluation of patient compliance
Abstract
Nasal continuous positive airway pressure (NCPAP) improves sleepiness and prognosis in obstructive sleep apnea (OSA). Our objective was to document NCPAP compliance and the percentage of time that the effective pressure shown to eliminate 95% of the obstructive apneas and hypopneas was maintained. We built and covertly installed an elapsed timer and mask pressure transducer recorder in NCPAP units of 47 OSA patients. Subjects were seen at 2- to 8-wk intervals over 6 months. Group mean age was 51 yr; 38 males, with mean body mass index of 42; all complained of daytime sleepiness. Initial full night polysomnography demonstrated a mean apnea-hypopnea index (AHI) of 58 +/- 2.6 SEM (range, 10 to 115). Nine subjects discontinued therapy within 3 months for various reasons. In the remaining subjects (n = 38) the actual mean nightly hours of use was 4.7 which represents 68% of the stated total sleep time (compliance). However, effective mean hours of use was 4.3 which represents 91% of the time that prescribed effective pressure was maintained at the mask. The AHI did not correlate with compliance, but did correlate with effective use (R = 0.27048, p = 0.0006). Subjective initial complaints of daytime sleepiness correlated with compliance only during the first visit (R = 0.38590, p = 0.05). No predictors for compliance were found.
Similar articles
-
[Results of 248 patients with sleep apnea syndrome treated by continuous positive pressure ventilation between 1990 and 1995. A study of compliance and outcome of the apnea-hypopnea index].Rev Mal Respir. 2000 Apr;17(2):467-74. Rev Mal Respir. 2000. PMID: 10859765 French.
-
[Nasal positive pressure ventilation (nCPAP) in therapy of obstructive sleep apnea: acceptance by 50 patients].Laryngorhinootologie. 1994 Nov;73(11):581-5. doi: 10.1055/s-2007-997200. Laryngorhinootologie. 1994. PMID: 7818743 German.
-
[Therapy with nasal CPAP (continuous positive airway pressure) in patients with obstructive sleep apnea syndrome (OSAS). I: Long-term acceptance of nasal CPAP].Laryngorhinootologie. 1997 Sep;76(9):550-3. doi: 10.1055/s-2007-997477. Laryngorhinootologie. 1997. PMID: 9417184 German.
-
[Therapy with nasal CPAP (continuous positive airway pressure) in patients with obstructive sleep apnea syndrome (OSAS). II: Side-effects of nCPAP therapy. Effect on long-term acceptance].Laryngorhinootologie. 1997 Oct;76(10):608-13. doi: 10.1055/s-2007-997488. Laryngorhinootologie. 1997. PMID: 9445527 Review. German.
-
Compliance with continuous positive airway pressure therapy: assessing and improving treatment outcomes.Curr Opin Pulm Med. 2001 Nov;7(6):391-8. doi: 10.1097/00063198-200111000-00005. Curr Opin Pulm Med. 2001. PMID: 11706314 Review.
Cited by
-
Claustrophobic tendencies and continuous positive airway pressure therapy non-adherence in adults with obstructive sleep apnea.Heart Lung. 2015 Mar-Apr;44(2):100-6. doi: 10.1016/j.hrtlng.2015.01.002. Heart Lung. 2015. PMID: 25744632 Free PMC article.
-
Prospective audit of a respiratory sleep disorders service at District General Hospital level.Postgrad Med J. 1999 Jul;75(885):414-8. doi: 10.1136/pgmj.75.885.414. Postgrad Med J. 1999. PMID: 10474726 Free PMC article.
-
Severe upper airway obstruction during sleep.Clin Rev Allergy Immunol. 2003 Oct;25(2):191-210. doi: 10.1385/CRIAI:25:2:191. Clin Rev Allergy Immunol. 2003. PMID: 14573885 Review.
-
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment.J Neurol. 2022 Oct;269(10):5356-5367. doi: 10.1007/s00415-022-11182-z. Epub 2022 May 24. J Neurol. 2022. PMID: 35608659 Free PMC article.
-
Sleep quality, short-term and long-term CPAP adherence.J Clin Sleep Med. 2012 Oct 15;8(5):489-500. doi: 10.5664/jcsm.2138. J Clin Sleep Med. 2012. PMID: 23066359 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical